These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 14529503)
1. The use of molecular descriptors in the design of gadolinium (III) chelates as MRI contrast agents. Maiocchi A Mini Rev Med Chem; 2003 Dec; 3(8):845-59. PubMed ID: 14529503 [TBL] [Abstract][Full Text] [Related]
2. Quantitative structure-property relationship (correlation analysis) of phosphonic acid-based chelates in design of MRI contrast agent. Tiwari AK; Ojha H; Kaul A; Dutta A; Srivastava P; Shukla G; Srivastava R; Mishra AK Chem Biol Drug Des; 2009 Jul; 74(1):87-91. PubMed ID: 19519748 [TBL] [Abstract][Full Text] [Related]
3. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action. Caravan P Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207 [TBL] [Abstract][Full Text] [Related]
4. Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review. Port M; Idée JM; Medina C; Robic C; Sabatou M; Corot C Biometals; 2008 Aug; 21(4):469-90. PubMed ID: 18344005 [TBL] [Abstract][Full Text] [Related]
5. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170 [TBL] [Abstract][Full Text] [Related]
7. The developmental history of the gadolinium chelates as intravenous contrast media for magnetic resonance. Runge VM; Ai T; Hao D; Hu X Invest Radiol; 2011 Dec; 46(12):807-16. PubMed ID: 22094366 [TBL] [Abstract][Full Text] [Related]
18. A DNA-binding Gd chelate for the detection of cell death by MRI. Garanger E; Hilderbrand SA; Blois JT; Sosnovik DE; Weissleder R; Josephson L Chem Commun (Camb); 2009 Aug; (29):4444-6. PubMed ID: 19597620 [TBL] [Abstract][Full Text] [Related]
19. An MRI contrast agent based on a zwitterionic metal-chelating polymer for hepatorenal angiography and tumor imaging. Zhang P; Wang Z; Wang Y; Wang Y; Liu C; Cao K; Lu Y; Behboodpour L; Hou Y; Gao M J Mater Chem B; 2020 Aug; 8(31):6956-6963. PubMed ID: 32490870 [TBL] [Abstract][Full Text] [Related]
20. AAZTA-based bifunctional chelating agents for the synthesis of multimeric/dendrimeric MRI contrast agents. Gugliotta G; Botta M; Tei L Org Biomol Chem; 2010 Oct; 8(20):4569-74. PubMed ID: 20740241 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]